HHMI
ENOV icon

Howard Hughes Medical Institute’s Enovis ENOV Stock Holding History

Howard Hughes Medical Institute’s Portfolio ENOV Stock Details ENOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-556
Closed -$49K – 171
2014
Q4 		$49K Buy
+556
New +$50.4K 0.01% 156
2013
Q3 		– Sell
-689
Closed -$62K – 210
2013
Q2 		$62K Buy
+689
New +$56.8K 0.02% 154

Other funds holding ENOV

BCP
BDT Capital Partners Chicago, Illinois $3.51B AUM 31.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Howard Hughes Medical Institute's ENOV Position: Q1 2015 in Review

Howard Hughes Medical Institute sold out of Enovis (ENOV) in Q1 2015, closing a stake of 556 shares — an estimated $49K sold.

Howard Hughes Medical Institute first reported a position in ENOV in Q2 2013 and held it in 2 quarters. The position peaked at $62K in Q2 2013. 200 funds tracked by Wall St. Rank hold ENOV as of Q1 2015.

  • Howard Hughes Medical Institute reported no remaining Enovis position as of Q1 2015 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 556 Enovis shares in Q1 2015, an estimated $49K.
  • Howard Hughes Medical Institute first reported a position in Enovis in Q2 2013 and held it in 2 quarters.
  • Howard Hughes Medical Institute's Enovis position peaked at $62K in Q2 2013.
  • 200 funds tracked by Wall St. Rank held Enovis as of Q1 2015.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2015, filed 14 May 2015.